Home › Forums › Infexion Connexion › Invitation to participate in research on the impact of Clostridium difficile on hospitals and residential aged care facilities
- This topic has 0 replies, 1 voice, and was last updated 4 years, 2 months ago by officemanager@ACIPC.ORG.AU Subject: Invitation to participate in research on the impact of Clostridium difficile on hospitals and residential aged care facilities MIME-Version: 1.0 Content-Type: multipart/alterna.
-
AuthorPosts
-
30/09/2020 at 3:31 pm #77358officemanager@ACIPC.ORG.AU Subject: Invitation to participate in research on the impact of Clostridium difficile on hospitals and residential aged care facilities MIME-Version: 1.0 Content-Type: multipart/alternaParticipant
Author:
officemanager@ACIPC.ORG.AU Subject: Invitation to participate in research on the impact of Clostridium difficile on hospitals and residential aged care facilities MIME-Version: 1.0 Content-Type: multipart/alternaEmail:
031f01d696ea$f57d94d0$e078be70$@acipc.org.auOrganisation:
State:
Although much is known about the diagnosis, treatment and impact on patients
with Clostridium difficile infection (CDI), less is known about the impact
of CDI on the operation of a hospital or a residential aged care facility
(RACF).PharmConsult, an independent specialist hospital consultancy, is conducting
market research into this aspect of CDI.To assist this research, we are seeking to interview infection control
nurses or consultants who have:* experience in CDI in public hospitals, private hospitals and RACFs;
* ideally experience in CDI management across a number of Australian states
and territories; and* knowledge of the impact of CDI on the operation and processes in
hospitals and RACFs.The interview will:
* take no longer than one hour;
* be conduct during the fortnight of 5 October 2020 to 16 October 2020 (but
this period can be flexible) at a time convenient for the interviewee; and* will be conducted via videoconference (Teams or Zoom).
An honorarium of $200 will be provided to interviewees.
If you would like to participate, please contact Michael Ryan, Managing
Director of PharmConsult via email at m.ryan@pharmconsult.com.au
providing a summary of your experience
and knowledge in regard to CDI (as per the three dot points above).More information on the project can be provided by phoning Michael on 0400
602 402.Michael Ryan
Project Manager
30 September 2020
http://www.pharmconsult.com.au
Kind regards,
Sara Kirby
Australasian Office Manager
+61 3 6281 9239
0429 294 033
228 Liverpool Street, Hobart TAS 7000, Australia
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
-
AuthorPosts
- The forum ‘Infexion Connexion’ is closed to new topics and replies.